BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37022163)

  • 21. Glycoprotein G is a virulence factor in infectious laryngotracheitis virus.
    Devlin JM; Browning GF; Hartley CA; Kirkpatrick NC; Mahmoudian A; Noormohammadi AH; Gilkerson JR
    J Gen Virol; 2006 Oct; 87(Pt 10):2839-2847. PubMed ID: 16963741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses to infectious laryngotracheitis virus.
    Coppo MJ; Hartley CA; Devlin JM
    Dev Comp Immunol; 2013 Nov; 41(3):454-62. PubMed ID: 23567343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative genome analysis of Korean field strains of infectious laryngotracheitis virus.
    La TM; Choi EJ; Lee JB; Park SY; Song CS; Choi IS; Lee SW
    PLoS One; 2019; 14(2):e0211158. PubMed ID: 30730935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo characterization of glycoprotein C-deleted infectious laryngotracheitis virus.
    Pavlova SP; Veits J; Blohm U; Maresch C; Mettenleiter TC; Fuchs W
    J Gen Virol; 2010 Apr; 91(Pt 4):847-57. PubMed ID: 19940061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and application of high-resolution melting analysis for the classification of infectious laryngotracheitis virus strains and detection of recombinant progeny.
    Fakhri O; Hartley CA; Devlin JM; Browning GF; Noormohammadi AH; Lee SW
    Arch Virol; 2019 Feb; 164(2):427-438. PubMed ID: 30421085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
    Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of the minimum protective dose of a glycoprotein-G-deficient infectious laryngotracheitis virus vaccine delivered via eye-drop to week-old chickens.
    Korsa MG; Devlin JM; Hartley CA; Browning GF; Coppo MJC; Quinteros JA; Loncoman CA; Onasanya AE; Thilakarathne D; Diaz-Méndez A
    PLoS One; 2018; 13(12):e0207611. PubMed ID: 30521554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague.
    Veits J; Lüschow D; Kindermann K; Werner O; Teifke JP; Mettenleiter TC; Fuchs W
    J Gen Virol; 2003 Dec; 84(Pt 12):3343-3352. PubMed ID: 14645915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune Responses in the Eye-Associated Lymphoid Tissues of Chickens after Ocular Inoculation with Vaccine and Virulent Strains of the Respiratory Infectious Laryngotracheitis Virus (ILTV).
    Beltrán G; Hurley DJ; Gogal RM; Sharif S; Read LR; Williams SM; Jerry CF; Maekawa DA; García M
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31295877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of A20 infectious laryngotracheitis vaccine take in meat chickens using swab and dust samples following mass vaccination in drinking water.
    Assen AM; Stillman M; Alfirevich S; Gerber PF; Groves PJ; Walkden-Brown SW
    Vet Microbiol; 2020 Dec; 251():108903. PubMed ID: 33176212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular exposure to infectious laryngotracheitis virus alters leukocyte subsets in the head-associated lymphoid tissues and trachea of 6-week-old White Leghorn chickens.
    Krunkosky M; García M; Beltran G; Williams SM; Hurley DJ; Gogal RM
    Avian Pathol; 2020 Aug; 49(4):404-417. PubMed ID: 32301627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection of Broilers with Two Virulent Strains of Infectious Laryngotracheitis Virus: Criteria for Evaluation of Experimental Infections.
    Vagnozzi A; Riblet SM; Williams SM; Zavala G; García M
    Avian Dis; 2015 Sep; 59(3):394-9. PubMed ID: 26478158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectious Laryngotracheitis Virus Viral Chemokine-Binding Protein Glycoprotein G Alters Transcription of Key Inflammatory Mediators
    Coppo MJC; Devlin JM; Legione AR; Vaz PK; Lee SW; Quinteros JA; Gilkerson JR; Ficorilli N; Reading PC; Noormohammadi AH; Hartley CA
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of the complete genome sequences of two Australian origin live attenuated vaccines of infectious laryngotracheitis virus.
    Lee SW; Devlin JM; Markham JF; Noormohammadi AH; Browning GF; Ficorilli NP; Hartley CA; Markham PF
    Vaccine; 2011 Dec; 29(52):9583-7. PubMed ID: 22044743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A practical method for assessing infectious laryngotracheitis vaccine take in broilers following mass administration in water: Spatial and temporal variation in viral genome content of poultry dust after vaccination.
    Ahaduzzaman M; Groves PJ; Sharpe SM; Williamson SL; Gao YK; Nguyen TV; Gerber PF; Walkden-Brown SW
    Vet Microbiol; 2020 Feb; 241():108545. PubMed ID: 31928697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.
    Han MG; Kim SJ
    Avian Dis; 2003; 47(2):261-71. PubMed ID: 12887186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The route of inoculation dictates the replication patterns of the infectious laryngotracheitis virus (ILTV) pathogenic strain and chicken embryo origin (CEO) vaccine.
    Beltrán G; Williams SM; Zavala G; Guy JS; García M
    Avian Pathol; 2017 Dec; 46(6):585-593. PubMed ID: 28532159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuation and Protection Efficacy of a Recombinant Infectious Laryngotracheitis Virus (ILTV) Depleted of Open Reading Frame C (ΔORFC) when Delivered in ovo.
    Schneiders GH; Riblet SM; García M
    Avian Dis; 2018 Jun; 62(2):143-151. PubMed ID: 29944395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In ovo vaccination of commercial broilers with a glycoprotein J gene-deleted strain of infectious laryngotracheitis virus.
    Mashchenko A; Riblet SM; Zavala G; García M
    Avian Dis; 2013 Jun; 57(2 Suppl):523-31. PubMed ID: 23901771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.